Dr Ullman has served as a Non-Executive Director on our board of directors since September 2015.
Since 2019, Dr Ullman has served as a Non-Executive Director on the board of Sobi, where he was Head of Research and Development and Chief Medical Officer from January 2022 to March 2023. From 2015 to 2018, he was Head of the COPD Centre at Sahlgrenska University Hospital, Sweden, and from 2013 to 2014, was Executive Vice President and Head of Research and Development in the BioScience business unit of Baxter International, a healthcare company that became Baxalta. From 2007 to 2013, Dr Ullman was Executive Vice President, Head of Research and Development at Nycomed Pharma, which was acquired by Takeda Pharmaceutical. Dr Ullman received a MD and a PhD in clinical pharmacology from the University of Gothenburg.
